Follow
Suraj B. Sable
Suraj B. Sable
Staff Scientist, Immunology, Centers for Disease Control and Prevention
Verified email at cdc.gov
Title
Cited by
Cited by
Year
Nanobead-based interventions for the treatment and prevention of tuberculosis
G Griffiths, B Nyström, SB Sable, GK Khuller
Nature Reviews Microbiology 8 (11), 827-834, 2010
1842010
Bacillus Calmette-Guerin vaccination using a microneedle patch
Y Hiraishi, S Nandakumar, SO Choi, JW Lee, YC Kim, JE Posey, ...
Vaccine 29 (14), 2626-2636, 2011
1162011
Tuberculosis vaccine development: progress in clinical evaluation
SB Sable, JE Posey, TJ Scriba
Clinical microbiology reviews 33 (1), 10.1128/cmr. 00100-19, 2019
1032019
An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection
KA Birkness, J Guarner, SB Sable, RA Tripp, KL Kellar, J Bartlett, ...
Immunology and cell biology 85 (2), 160-168, 2007
822007
Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin
FB Sow, S Nandakumar, V Velu, KL Kellar, LS Schlesinger, RR Amara, ...
Tuberculosis 91 (4), 314-321, 2011
772011
Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity
SB Sable, M Kalra, I Verma, GK Khuller
Clinical immunology 122 (3), 239-251, 2007
672007
Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis
PK Giri, SB Sable, I Verma, GK Khuller
FEMS Immunology & Medical Microbiology 45 (1), 87-93, 2005
622005
Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis
SB Sable, I Verma, GK Khuller
Vaccine 23 (32), 4175-4184, 2005
562005
Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models …
SB Sable, R Kumar, M Kalra, I Verma, GK Khuller, K Dobos, JT Belisle
Infection and immunity 73 (6), 3547-3558, 2005
542005
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice
M Kalra, A Grover, N Mehta, J Singh, J Kaur, SB Sable, D Behera, ...
Clinical Immunology 125 (2), 173-183, 2007
482007
Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination
SB Sable, M Cheruvu, S Nandakumar, S Sharma, K Bandyopadhyay, ...
PLoS One 6 (7), e22718, 2011
412011
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice
S Nandakumar, S Kannanganat, JE Posey, RR Amara, SB Sable
PLoS One 9 (11), e113951, 2014
402014
O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection
S Nandakumar, S Kannanganat, KM Dobos, M Lucas, JS Spencer, ...
PLoS pathogens 9 (10), e1003705, 2013
402013
Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins
SB Sable, D Goyal, I Verma, D Behera, GK Khuller
European Respiratory Journal 29 (2), 337-346, 2007
332007
Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens
SB Sable, BB Plikaytis, TM Shinnick
Vaccine 25 (9), 1553-1566, 2007
302007
Human immune recognition-based multicomponent subunit vaccines against tuberculosis
SB Sable, I Verma, D Behera, GK Khuller
European Respiratory Journal 25 (5), 902-910, 2005
282005
Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis
S Nandakumar, S Kannanganat, KM Dobos, M Lucas, JS Spencer, ...
Scientific reports 6 (1), 25837, 2016
262016
Polypeptide vaccine and vaccination strategy against mycobacterium
S Sable, BB Plikaytis, TM Shinnick, RR Amara, M Cheruvu
US Patent 8,741,313, 2014
252014
Polypeptide vaccine and vaccination strategy against mycobacterium
S Sable, BB Plikaytis, TM Shinnick, RR Amara, M Cheruvu
US Patent 8,741,313, 2014
252014
Polypeptide vaccine and vaccination strategy against mycobacterium
S Sable, BB Plikaytis, TM Shinnick, RR Amara, M Cheruvu
US Patent 8,741,313, 2014
252014
The system can't perform the operation now. Try again later.
Articles 1–20